NEW YORK, Nov. 7, 2019 /PRNewswire/ -- The Lupus Research Alliance (LRA), the largest private funder of lupus research in the world, announced today that 16 studies supported by the organization will be presented at the 2019 ACR/ARP Annual Meeting November 8-13, 2019. In addition, results of two positive clinical studies conducted by LRA's a

NEW YORK, Nov. 7, 2019 /PRNewswire/ -- Researchers at Hospital for Special Surgery (HSS) in New York City are enrolling patients in a study using cutting-edge imaging technology to produce three-dimensional maps of the spine in people with scoliosis. 

CHICAGO, Nov. 7, 2019 /PRNewswire/ -- To help patients suffering from a substance use disorder find facilities that deliver quality treatment and care, Blue Cross and Blue Shield of Illinois (BCBSIL) recognizes Symetria Recovery®'s Naperville and Des Plaines, I

ST. LOUIS, Nov. 7, 2019 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today issued a reminder that it will host an investor meeting, including a question-and-answer session, on Friday, December 13, 2019. Michael F. Neidorff, Chairman, President and Chief Executive Officer, and Jeffrey

WASHINGTON, Nov. 7, 2019 /PRNewswire/ -- Medicomp Systems, the leading provider of physician-driven point-of-care solutions that fix EHRs, announced today that Toni J.

Dr. Johanne Kaplan highlights need for precision selectivity for the toxic form of amyloid beta in narrated overview TORONTO and CAMBRIDGE, MA, Nov. 7, 2019 /PRNewswire/ - ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the di

SOUTH SAN FRANCISCO, Calif., Nov. 7, 2019 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), today announced that data related to TAVALISSE® (fostamatinib disodium hexahydrate) tablets has been accepted for two poster presentations at the 61st American Society of Hematology (ASH) Annual Meeting & Exposition to be held December 7-10

CRANBURY, N.J., Nov. 7, 2019 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its first quarter fiscal year 2020 operating results on Wednesday, November 13, 2019 before the open of the U.S. financial markets.

MALVERN, Pa., Nov. 7, 2019 /PRNewswire/ -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, will present its latest patient treatment data and key findings at the 15th Annual Neuroscience Educatio

GERMANTOWN, Md., Nov. 7, 2019 /PRNewswire/ -- Triple-Gene LLC, a clinical stage cardiovascular gene therapy company and majority owned subsidiary of Intrexon Corporation (NASDAQ: XON), today announced